Sage Journals: Discover world-class research

Abstract

Introduction

The PREdiction of Survival on ECMO Therapy Score (PRESET-Score) predicts mortality while on veno-venous extracorporeal membrane oxygenation (VV ECMO) for acute respiratory distress syndrome. The aim of our study was to assess the association between PRESET-Score and survival in a large COVID-19 VV ECMO cohort.

Methods

This was a single-center retrospective study of COVID-19 VV ECMO patients from 15 March 2020, to 30 November 2021. Univariable and Multivariable analyses were performed to assess patient survival and score differences.

Results

A total of 105 patients were included in our analysis with a mean PRESET-Score of 6.74. Overall survival was 65.71%. The mean PRESET-Score was significantly lower in the survivor group (6.03 vs 8.11, p < 0.001). Patients with a PRESET-Score less than or equal to six had improved survival compared to those with a PRESET-Score greater than or equal to 8 (97.7% vs. 32.5%, p < 0.001). In a multivariable logistic regression, a lower PRESET-Score was also predictive of survival (OR 2.84, 95% CI 1.75, 4.63, p < 0.001).

Conclusion

We demonstrate that lower PRESET scores are associated with improved survival. The utilization of this validated, quantifiable, and objective scoring system to help identify COVID-19 patients with the greatest potential to benefit from VV-ECMO appears feasible. The incorporation of the PRESET-Score into institutional ECMO candidacy guidelines can help insure and improve access of this limited healthcare resource to all critically ill patients.

Keywords

circulatory support circulatory temporary support extracorporeal membrane oxygenation COVID-19

Get full access to this article

View all access options for this article.

References

Welker

Huang

Gil

IJN

, et al. Acute respiratory distress syndrome update, with coronavirus disease 2019 focus. J Cardiothorac Vasc Anesth 2021; 36(4): 1188–1195.

Combes

Peek

Hajage

, et al. ECMO for severe ARDS: systematic review and individual patient data meta-analysis. Intensive Care Med 2020; 46(11): 2048–2057.

Singh

Hote

. Ventilatory management of patients on ECMO. Indian J Thorac Cardiovasc Surg 2021; 37(Suppl 2): 248–253.

Munshi

Walkey

Goligher

, et al. Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis. Lancet Respir Med 2019; 7(2): 163–172.

Hilder

Herbstreit

Adamzik

, et al. Comparison of mortality prediction models in acute respiratory distress syndrome undergoing extracorporeal membrane oxygenation and development of a novel prediction score: the PREdiction of Survival on ECMO Therapy-Score (PRESET-Score). Crit Care 2017; 21(1): 301.

Tabatabai

Ghneim

Kaczorowski

, et al. Mortality risk assessment in COVID-19 venovenous extracorporeal membrane oxygenation. Ann Thorac Surg 2021; 112(6): 1983–1989.

Scalea

Rubinson

Tran

, et al. Critical care resuscitation unit: an innovative solution to expedite transfer of patients with time-sensitive critical illness. J Am Coll Surg 2016; 222(4): 614–621.

Menaker

Dolly

Rector

, et al.

The lung rescue unit-Does a dedicated intensive care unit for venovenous extracorporeal membrane oxygenation improve survival to discharge?

J Trauma Acute Care Surg 2017; 83(3): 438–442.

Badulak

Antonini

Stead

, et al. Extracorporeal membrane oxygenation for COVID-19: updated 2021 guidelines from the extracorporeal life support organization. ASAIO J 2021; 67(5): 485–495.

10.

Shekar

Badulak

Peek

, et al. Extracorporeal life support organization coronavirus disease 2019 interim guidelines: a consensus document from an international group of interdisciplinary extracorporeal membrane oxygenation providers. ASAIO J 2020; 66(7): 707–721.

11.

Harris

Taylor

Thielke

, et al. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42(2): 377–381.

12.

Harris

Taylor

Minor

, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform 2019; 95: 1–24.

13.

Meduri

Headley

Golden

, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998; 280(2): 159–165.

14.

Villar

Belda

Anon

, et al. Evaluating the efficacy of dexamethasone in the treatment of patients with persistent acute respiratory distress syndrome: study protocol for a randomized controlled trial. Trials. 2016;17:342.

15.

Le Gall

Lemeshow

Saulnier

. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270(24): 2957–2963.

16.

Joshi

Flanagan

Subramanian

, et al. Respiratory ECMO Survival Prediction (RESP) Score for COVID-19 Patients Treated with ECMO. ASAIO J 2022; 68(4): 486–491.

17.

Ahuja

Shekar

. Patient selection for VV ECMO: have we found the crystal ball? J Thorac Dis 2018; 10(Suppl 17): S1979–S1981.

18.

Jones

Aborn

Kline

. Severity of emergency department hypotension predicts adverse hospital outcome. Shock 2004; 22(5): 410–414.

19.

Patel

Heizer

O’Connor

, et al. Hypotension during hospitalization for acute heart failure is independently associated with 30-day mortality: findings from ASCEND-HF. Circ Heart Fail 2014; 7(6): 918–925.

20.

Sun

Wang

, et al. Predictors of mortality in hospitalized COVID-19 patients complicated with hypotension and hypoxemia: a retrospective cohort study. Front Med (Lausanne) 2021; 8: 753035.

21.

Vandijck

Blot

De Waele

, et al. Thrombocytopenia and outcome in critically ill patients with bloodstream infection. Heart Lung 2010; 39(1): 21–26.

22.

Jiritano

Serraino

Ten Cate

, et al. Platelets and extra-corporeal membrane oxygenation in adult patients: a systematic review and meta-analysis. Intensive Care Med 2020; 46(6): 1154–1169.

23.

Carpene

Onorato

Nocini

, et al. Blood lactate concentration in COVID-19: a systematic literature review. Clin Chem Lab Med 2021.

24.

Pappalardo

Pieri

Greco

, et al. Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: the ECMOnet score. Intensive Care Med 2013; 39(2): 275–281.

25.

Schmidt

Bailey

Sheldrake

, et al. Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score. Am J Respir Crit Care Med 2014; 189(11): 1374–1382.

26.

Diaz

Heller

. Barotrauma and Mechanical Ventilation. Treasure Island FL: StatPearls, 2022.

27.

Khamees

Bani-Issa

Zoubi

MSA

, et al. SARS-CoV-2 and coronavirus disease mitigation: treatment options, vaccinations and variants. Pathogens 2022; 11(2): 275.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.08 MB

Decreased PRESET-Score corresponds with improved survival in COVID-19 veno-venous extracorporeal membrane oxygenation